Search

You searched for "wound"

3292 results found
Otology & Neurotology journal cover image.

A raised neutrophil / lymphocyte ratio predicts vestibular schwannoma growth

1 September 2016 |
It has long been known that the neutrophil to lymphocyte count ratio (NLR) is a marker of inflammation and that a higher ratio relates to poorer outcomes in some malignant tumours including some head and neck cancers. Neutrophilia (and therefore...

Recurrent seroma in cochlear implanted patients

1 July 2019 | | ENTA - Neurotology
Little is known about why some patients experience recurrent seromas over the implant package and in the absence of any cause, antibiotics are frequently prescribed as a precaution to protect the implant from infection. A tertiary referral centre selected five...

Use of technological aids and interpretation services

1 November 2017 | | Assistive technology, cochlear implant, hearing aid satisfaction, hearing aids
Hearing loss attracts large interest among researchers all over the world due to its prevalence and negative psychological side-effects. Usually hearing loss is managed with hearing aids. However, there are several additional technologies that can be of great help for...
Otolaryngologic Clinics cover image.

Office treatment for persistent rhinorrhoea

4 September 2025 | | ENTA - Rhinology / Sinus
Vasomotor rhinitis (VR) is a common condition across the world. Patients suffering from VR commonly have symptoms of persistent bilateral rhinorrhoea, that can have a significant negative impact on their quality of life. Vasomotor rhinitis can be treated medically with...

Well drilling vs. subperiosteal pocket for cochlear implants – comparison of operative time, complications and cost-effectiveness

1 July 2021 | | ENTA - Neurotology, ENTA - Otology
The choice of method for securing the receiver/stimulator (R/S) package during cochlear implant surgery is usually dependant on several factors, but primarily surgeon preference. The initial recommendation from manufacturers was to drill a bony well (WD technique) and use bony...

Sustainable Practice

3 November 2023 |
Guest Section Editor Brian D Westerberg, MD, FRCSC, MHSc, Clinical Professor, University of British Columbia, Canada; Head, Division of Otolaryngology – Head and Neck Surgery, Providence Health Care, Vancouver, Canada. Climate change is the greatest threat to human health today....

True Cut – a dramatic biopsy from the world of surgery

1 July 2018 | | ENTA - Otology
True Cut is a stage play that asks: “What happens when things go wrong in healthcare?” It brings the hidden world of the operating theatre onto the theatre stage. ENT surgeon, David Alderson, talks about how the play came about....

In conversation with Prof Nobuhiko Isshiki

7 January 2020 | | ENTA - Laryngology / Swallowing / Voice
A 90th birthday is definitely a landmark that should be observed and celebrated. Elisabeth Sjögren interviews this man who has been such a huge influence in the world of laryngology. Nobuhiko and Keiko in the cosmos field. Congratulations on your...

Timing of surgery in chronic rhinosinusitis: does it matter?

1 July 2016 | | ENTA - Rhinology / Sinus
While many patients with chronic rhinosinusitis respond to medical treatment, some do not. The next step for these patients is surgery, but how soon should this be offered? Sooner rather than later seems to be the answer, as Claire Hopkins...

Embracing the changes prompted by lockdown

2 November 2020 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic
March 2020 introduced the concept of lockdown to audiology services in the NHS, prompting a rethink of how to best provide hearing care. In this issue, we hear from Hanna Jeffery, a Clinical Scientist working at the Royal Glamorgan Hospital...

COOL therapy for cisplatin-induced hearing loss

5 July 2022 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Nature Communications Medicine publishes positive, real-world data for tinnitus patients treated with unique, FDA approved stimulation device

9 May 2025 | Company Profiles, Research & Development
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...